Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

NIH’s continued investment fuels TMJ pain research

Chronic pain is one of the most common health conditions worldwide. Back pain is the most frequently reported type, followed closely by head and face pain linked to the jaw joint, in the form of temporomandibular joint (TMJ) disorder.

27 Feb 2026

Mendelian randomization study reveals opposing roles for IL6 and IL6R in long-term mortality

A new research paper was published in Volume 18 of Aging-US on February 6, 2026, titled "Causal effects of inflammation on long-term mortality: a Mendelian randomization study."

27 Feb 2026

Textile-based system advances real-world cardiovascular monitoring

Cardiovascular diseases remain the leading global cause of mortality, claiming nearly 18 million lives each year.

26 Feb 2026

Rising vitamin K shot refusal increases newborn brain injury risk

Increasing numbers of parents are refusing vitamin K shots for their newborns, putting infants at greater risk of avoidable brain injuries, according to a preliminary systematic review released February 26, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

26 Feb 2026

Heart attack deaths increase in young adults, especially women

A new study found that heart attack deaths were up among younger adults with women more likely than men to die after a first heart attack.

26 Feb 2026

Assessing the value of modern US healthcare gains

Over two decades, medical care improvements increased health spans in the U.S. by 1.3 years and medical spending by $234,000 per person over their lifetime – or about $182,000 per additional healthy year of life gained – when measured from birth. These are among the key findings in a new in-depth national study published today in Value in Health.

26 Feb 2026

Daily aspirin not reliable for preventing bowel cancer

Daily aspirin use does not offer a quick or reliable way to prevent bowel cancer in the general population and carries immediate risks of serious bleeding, a new Cochrane review finds.

25 Feb 2026

Ketogenic diet alters brain signaling to reduce epileptic seizures

A ketogenic diet - one that is high in fat and extremely low in carbohydrates - has been known for decades to reduce seizures in some epilepsy patients.

25 Feb 2026

Morning chronotype and exercise associated with reduced ALS risk

Being an early bird, also called a morning person, and being more physically active are associated with lower risks of amyotrophic lateral sclerosis (ALS), according to a preliminary study released February 25, 2026, that will be presented at the American Academy of Neurology's 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

25 Feb 2026

Prior COVID infection increases kidney disease risk

Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste and excess water from the blood are damaged, according to the Centers for Disease Control and Prevention.

25 Feb 2026

Smoking status influences Parkinson's disease risk and mortality outcomes

A new study of smokers finds that currently smoking is associated with a lower risk of developing Parkinson's disease, but quitting smoking was associated with a lower risk of death.

25 Feb 2026

Study finds brain changes related to worse memory in football players with repetitive head impacts

In former college and professional football players, a new study has found higher levels of inflammation were associated with worse brain structure, which in turn was related to worse memory.

25 Feb 2026

Combining healthy lifestyle and GLP-1 therapy reduces heart risks in diabetes

Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy lifestyle habits, according to a new study led by researchers at Harvard T.H. Chan School of Public Health and the Department of Veterans Affairs Boston Healthcare System.

25 Feb 2026

Road traffic noise linked to immediate heart and blood vessel stress

A new study published in the journal Cardiovascular Research shows that a single night of road traffic noise, at levels that are typical of those living in a city, causes stress to the heart and blood vessels.

25 Feb 2026

Study reveals gaps in life-saving antenatal treatments for premature babies

A new global analysis of two antenatal treatments that reduce the risk of cerebral palsy and respiratory complications in premature babies reveals significant international variation in implementation.

25 Feb 2026

Nearly 6 in 10 women in the U.S. may have cardiovascular disease in the next 25 years

Driven by rising rates in high blood pressure, nearly 6 in 10 women in the U.S. will have some type of cardiovascular disease (CVD) in the next 25 years, according to a new scientific statement published today in Circulation, the peer-reviewed, flagship journal of the American Heart Association, a global force changing the future of health for all.

25 Feb 2026

Hip exoskeleton reduces walking effort in stroke survivors

A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body.

24 Feb 2026

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well tolerated but did not achieve statistically significant weight loss compared with placebo at 4 mg or 6 mg doses. Although the higher dose showed modest within-group weight reduction and improved HbA1c, unexpectedly substantial placebo-associated weight loss limited the observed treatment effect.

24 Feb 2026

ChatGPT Health fails critical emergency and suicide safety tests

ChatGPT Health, a widely used consumer artificial intelligence (AI) tool that provides health guidance directly to the public-including advice about how urgently to seek medical care-may fail to direct users appropriately to emergency care in a significant number of serious cases, according to researchers at the Icahn School of Medicine at Mount Sinai.

24 Feb 2026

Rethinking cardiovascular risk assessment in women

Less artery-clogging plaque in women's arteries did not appear to protect them from heart disease compared to men, according to a study published in Circulation: Cardiovascular Imaging, an American Heart Association journal.

23 Feb 2026